vs
Side-by-side financial comparison of Insulet Corporation (PODD) and SERVICE CORP INTERNATIONAL (SCI). Click either name above to swap in a different company.
SERVICE CORP INTERNATIONAL is the larger business by last-quarter revenue ($1.1B vs $783.7M, roughly 1.4× Insulet Corporation). SERVICE CORP INTERNATIONAL runs the higher net margin — 14.3% vs 13.0%, a 1.4% gap on every dollar of revenue. On growth, Insulet Corporation posted the faster year-over-year revenue change (31.2% vs 1.7%). SERVICE CORP INTERNATIONAL produced more free cash flow last quarter ($87.2M vs $48.2M). Over the past eight quarters, Insulet Corporation's revenue compounded faster (33.2% CAGR vs 3.1%).
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy . The device configuration may vary depending on design. A traditional pump includes:the pump a disposable reservoir for insulin a disposable infusion set, including a cannula for subcutaneous insertion and a tubing system to connect the insulin reservoir to the cannula.
International Distribution Services Limited is a British company providing postal and courier services. IDS was created in 2013 by the UK government as a new holding company of Royal Mail, and a majority of its shares were then sold on the London Stock Exchange, with the government initially retaining a 30 per cent at the time. As of April 2025, IDS is owned and operated by Czech-based EP Group, owned by Daniel Křetínský.
PODD vs SCI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $783.7M | $1.1B |
| Net Profit | $101.6M | $159.4M |
| Gross Margin | 72.6% | 28.0% |
| Operating Margin | 18.7% | 24.8% |
| Net Margin | 13.0% | 14.3% |
| Revenue YoY | 31.2% | 1.7% |
| Net Profit YoY | 0.9% | 5.3% |
| EPS (diluted) | $1.42 | $1.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $783.7M | $1.1B | ||
| Q3 25 | $706.3M | $1.1B | ||
| Q2 25 | $649.1M | $1.1B | ||
| Q1 25 | $569.0M | $1.1B | ||
| Q4 24 | $597.5M | $1.1B | ||
| Q3 24 | $543.9M | $1.0B | ||
| Q2 24 | $488.5M | $1.0B | ||
| Q1 24 | $441.7M | $1.0B |
| Q4 25 | $101.6M | $159.4M | ||
| Q3 25 | $87.6M | $117.5M | ||
| Q2 25 | $22.5M | $122.9M | ||
| Q1 25 | $35.4M | $142.9M | ||
| Q4 24 | $100.7M | $151.4M | ||
| Q3 24 | $77.5M | $117.8M | ||
| Q2 24 | $188.6M | $118.2M | ||
| Q1 24 | $51.5M | $131.3M |
| Q4 25 | 72.6% | 28.0% | ||
| Q3 25 | 72.2% | 25.1% | ||
| Q2 25 | 69.7% | 25.5% | ||
| Q1 25 | 71.9% | 27.1% | ||
| Q4 24 | 72.1% | 28.0% | ||
| Q3 24 | 69.3% | 24.9% | ||
| Q2 24 | 67.7% | 24.9% | ||
| Q1 24 | 69.5% | 26.2% |
| Q4 25 | 18.7% | 24.8% | ||
| Q3 25 | 16.7% | 21.4% | ||
| Q2 25 | 18.7% | 21.1% | ||
| Q1 25 | 15.6% | 23.4% | ||
| Q4 24 | 18.3% | 24.0% | ||
| Q3 24 | 16.2% | 20.9% | ||
| Q2 24 | 11.2% | 21.4% | ||
| Q1 24 | 12.9% | 22.2% |
| Q4 25 | 13.0% | 14.3% | ||
| Q3 25 | 12.4% | 11.1% | ||
| Q2 25 | 3.5% | 11.5% | ||
| Q1 25 | 6.2% | 13.3% | ||
| Q4 24 | 16.9% | 13.8% | ||
| Q3 24 | 14.2% | 11.6% | ||
| Q2 24 | 38.6% | 11.4% | ||
| Q1 24 | 11.7% | 12.6% |
| Q4 25 | $1.42 | $1.13 | ||
| Q3 25 | $1.24 | $0.83 | ||
| Q2 25 | $0.32 | $0.86 | ||
| Q1 25 | $0.50 | $0.98 | ||
| Q4 24 | $1.38 | $1.02 | ||
| Q3 24 | $1.08 | $0.81 | ||
| Q2 24 | $2.59 | $0.81 | ||
| Q1 24 | $0.73 | $0.89 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $243.6M |
| Total DebtLower is stronger | $930.8M | $5.1B |
| Stockholders' EquityBook value | $1.5B | $1.6B |
| Total Assets | $3.2B | $18.7B |
| Debt / EquityLower = less leverage | 0.61× | 3.10× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $243.6M | ||
| Q3 25 | — | $241.3M | ||
| Q2 25 | — | $255.4M | ||
| Q1 25 | — | $227.2M | ||
| Q4 24 | — | $218.8M | ||
| Q3 24 | — | $185.4M | ||
| Q2 24 | — | $184.4M | ||
| Q1 24 | — | $205.6M |
| Q4 25 | $930.8M | $5.1B | ||
| Q3 25 | $934.9M | $5.0B | ||
| Q2 25 | $939.0M | $5.0B | ||
| Q1 25 | $1.6B | $4.7B | ||
| Q4 24 | $1.3B | $4.8B | ||
| Q3 24 | $1.4B | $4.7B | ||
| Q2 24 | $1.4B | $4.7B | ||
| Q1 24 | $1.4B | $4.6B |
| Q4 25 | $1.5B | $1.6B | ||
| Q3 25 | $1.4B | $1.6B | ||
| Q2 25 | $1.5B | $1.6B | ||
| Q1 25 | $1.3B | $1.7B | ||
| Q4 24 | $1.2B | $1.7B | ||
| Q3 24 | $1.1B | $1.6B | ||
| Q2 24 | $998.4M | $1.5B | ||
| Q1 24 | $790.7M | $1.6B |
| Q4 25 | $3.2B | $18.7B | ||
| Q3 25 | $3.0B | $18.4B | ||
| Q2 25 | $3.5B | $18.0B | ||
| Q1 25 | $3.5B | $17.3B | ||
| Q4 24 | $3.1B | $17.4B | ||
| Q3 24 | $3.0B | $17.4B | ||
| Q2 24 | $2.9B | $16.8B | ||
| Q1 24 | $2.6B | $16.7B |
| Q4 25 | 0.61× | 3.10× | ||
| Q3 25 | 0.68× | 3.17× | ||
| Q2 25 | 0.64× | 3.19× | ||
| Q1 25 | 1.21× | 2.87× | ||
| Q4 24 | 1.07× | 2.83× | ||
| Q3 24 | 1.21× | 2.92× | ||
| Q2 24 | 1.36× | 3.05× | ||
| Q1 24 | 1.72× | 2.90× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $183.3M | $212.9M |
| Free Cash FlowOCF − Capex | $48.2M | $87.2M |
| FCF MarginFCF / Revenue | 6.2% | 7.8% |
| Capex IntensityCapex / Revenue | 17.2% | 11.3% |
| Cash ConversionOCF / Net Profit | 1.80× | 1.34× |
| TTM Free Cash FlowTrailing 4 quarters | $377.7M | $554.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $183.3M | $212.9M | ||
| Q3 25 | $125.7M | $252.3M | ||
| Q2 25 | $196.5M | $166.4M | ||
| Q1 25 | $63.8M | $311.1M | ||
| Q4 24 | $147.7M | $264.1M | ||
| Q3 24 | $98.5M | $263.8M | ||
| Q2 24 | $96.5M | $196.9M | ||
| Q1 24 | $87.6M | $220.1M |
| Q4 25 | $48.2M | $87.2M | ||
| Q3 25 | $100.1M | $150.7M | ||
| Q2 25 | $177.9M | $83.4M | ||
| Q1 25 | $51.5M | $233.0M | ||
| Q4 24 | $94.1M | $151.8M | ||
| Q3 24 | $71.8M | $162.8M | ||
| Q2 24 | $74.0M | $100.8M | ||
| Q1 24 | $65.5M | $140.3M |
| Q4 25 | 6.2% | 7.8% | ||
| Q3 25 | 14.2% | 14.2% | ||
| Q2 25 | 27.4% | 7.8% | ||
| Q1 25 | 9.1% | 21.7% | ||
| Q4 24 | 15.7% | 13.9% | ||
| Q3 24 | 13.2% | 16.1% | ||
| Q2 24 | 15.1% | 9.7% | ||
| Q1 24 | 14.8% | 13.4% |
| Q4 25 | 17.2% | 11.3% | ||
| Q3 25 | 3.6% | 9.6% | ||
| Q2 25 | 2.9% | 7.8% | ||
| Q1 25 | 2.2% | 7.3% | ||
| Q4 24 | 9.0% | 10.3% | ||
| Q3 24 | 4.9% | 10.0% | ||
| Q2 24 | 4.6% | 9.3% | ||
| Q1 24 | 5.0% | 7.6% |
| Q4 25 | 1.80× | 1.34× | ||
| Q3 25 | 1.43× | 2.15× | ||
| Q2 25 | 8.73× | 1.35× | ||
| Q1 25 | 1.80× | 2.18× | ||
| Q4 24 | 1.47× | 1.75× | ||
| Q3 24 | 1.27× | 2.24× | ||
| Q2 24 | 0.51× | 1.67× | ||
| Q1 24 | 1.70× | 1.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PODD
| U.S.Omnipod | $567.8M | 72% |
| International Omnipod | $214.0M | 27% |
| Drug Delivery | $1.9M | 0% |
SCI
| Cemetery | $510.9M | 46% |
| Funeral Matured Preneed Revenue | $196.5M | 18% |
| Cemetery Recognized Preneed Merchandise And Service Revenue | $107.4M | 10% |
| Cemetery Atneed Revenue | $104.9M | 9% |
| CA | $56.4M | 5% |
| Funeral Other Revenue | $54.6M | 5% |
| Cemetery Other Revenue | $40.2M | 4% |
| Nonfuneral Home Revenue | $28.1M | 3% |
| Non Funeral Home Preneed Sales Revenue | $22.0M | 2% |
